When translating the preclinical findings to clinical practice, targeting ALKBH5 and m6A demethylation emerges as a promising strategy to enhance osteoblast differentiation and alleviate inflammation in peri-implantitis patients. Here, ALKBH5 is linked to Peri-Implantitis.